Shares in Luminex (NSDQ:LMNX) rose today after the company beat expectations on Wall Street with its second quarter results.
The Austin, Tx.-based company posted profits of $5.5 million, or 13¢ per share, on sales of $76.5 million for the 3 months ended June 30, for bottom-line growth of -1.9% on sales growth of 19% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Luminex tops Q2 estimates appeared first on MassDevice.
from MassDevice http://ift.tt/2uDR86l
Cap comentari:
Publica un comentari a l'entrada